Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
How to switch disease-modifying treatments in multiple sclerosis: Guidelines from the French Multiple Sclerosis Society (SFSEP).
Bigaut K, Cohen M, Durand-Dubief F, Maillart E, Planque E, Zephir H, Lebrun-Frenay C, de Seze J; French Group for Recommendations in Multiple Sclerosis (France4MS) and the Société Française de la Sclérose En Plaques (SFSEP). Bigaut K, et al. Among authors: maillart e. Mult Scler Relat Disord. 2021 Aug;53:103076. doi: 10.1016/j.msard.2021.103076. Epub 2021 Jun 10. Mult Scler Relat Disord. 2021. PMID: 34161898
[New and emerging treatments for multiple sclerosis].
Louapre C, Maillart É, Papeix C, Lubetzki C. Louapre C, et al. Among authors: maillart e. Med Sci (Paris). 2013 Dec;29(12):1105-10. doi: 10.1051/medsci/20132912013. Epub 2013 Dec 20. Med Sci (Paris). 2013. PMID: 24356140 Free article. Review. French.
Switching from natalizumab to fingolimod in multiple sclerosis: a French prospective study.
Cohen M, Maillart E, Tourbah A, De Sèze J, Vukusic S, Brassat D, Anne O, Wiertlewski S, Camu W, Courtois S, Ruet A, Debouverie M, Le Page E, Casez O, Heinzlef O, Stankoff B, Bourre B, Castelnovo G, Rico A, Berger E, Camdessanche JP, Defer G, Clavelou P, Al Khedr A, Zephir H, Fromont A, Papeix C, Brochet B, Pelletier J, Lebrun C; Club Francophone de la Sclérose en Plaques Investigators. Cohen M, et al. Among authors: maillart e. JAMA Neurol. 2014 Apr;71(4):436-41. doi: 10.1001/jamaneurol.2013.6240. JAMA Neurol. 2014. PMID: 24566807 Clinical Trial.
Evaluation of French-language internet sites dealing with multiple sclerosis.
Guéguen A, Maillart E, Gallice T, Allaf B. Guéguen A, et al. Among authors: maillart e. Mult Scler J Exp Transl Clin. 2016 Jun 15;2:2055217316652419. doi: 10.1177/2055217316652419. eCollection 2016 Jan-Dec. Mult Scler J Exp Transl Clin. 2016. PMID: 28607728 Free PMC article.
Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome.
Maillart E, Vidal JS, Brassat D, Stankoff B, Fromont A, de Sèze J, Taithe F, Clavelou P, Bourre B, Delvaux V, Rico A, Labauge P, Tourbah A, Lebrun C, Pelletier J, Moreau T, Louapre C, Lubetzki C, Papeix C. Maillart E, et al. Neurol Neuroimmunol Neuroinflamm. 2017 Apr 14;4(3):e346. doi: 10.1212/NXI.0000000000000346. eCollection 2017 May. Neurol Neuroimmunol Neuroinflamm. 2017. PMID: 28616447 Free PMC article.
Fatigue evaluation in fingolimod treated patients: An observational study.
Masingue M, Debs R, Maillart E, Delvaux V, Lubetzki C, Vidal JS, Papeix C. Masingue M, et al. Among authors: maillart e. Mult Scler Relat Disord. 2017 May;14:8-11. doi: 10.1016/j.msard.2017.03.006. Epub 2017 Mar 14. Mult Scler Relat Disord. 2017. PMID: 28619437
Multiple sclerosis and aging.
Louapre C, Papeix C, Lubetzki C, Maillart E. Louapre C, et al. Among authors: maillart e. Geriatr Psychol Neuropsychiatr Vieil. 2017 Dec 1;15(4):402-408. doi: 10.1684/pnv.2017.0685. Geriatr Psychol Neuropsychiatr Vieil. 2017. PMID: 29081400 Review. English.
209 results